Stay updated on PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study locations were expanded to include numerous new sites across the U.S. and internationally, and several location groupings were removed.
    Difference
    2%
    Check dated 2025-12-23T21:19:39.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Publications section now states that items are automatically populated from PubMed and may not pertain to the study, and the page revision label has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:28:56.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removal of the government funding/operating-status notice from the page. This does not affect the study details, eligibility criteria, or endpoints presented in the ClinicalTrials.gov record.
    Difference
    0.2%
    Check dated 2025-11-18T06:53:03.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    No significant changes detected on the page. Content and layout appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T20:58:18.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page is updated to announce a funding-related operating status notice and to indicate a new version (v3.2.0), replacing the old v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T05:23:28.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Updated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.
    Difference
    0.2%
    Check dated 2025-09-29T03:03:13.000Z thumbnail image

Stay in the know with updates to PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-07081532 & Rybelsus in Type 2 Diabetes Clinical Trial page.